246 related articles for article (PubMed ID: 19208562)
1. Dendritic cells contribute to autoimmune kidney injury in MRL-Faslpr mice.
Iwata Y; Furuichi K; Sakai N; Yamauchi H; Shinozaki Y; Zhou H; Kurokawa Y; Toyama T; Kitajima S; Okumura T; Yamada S; Maruyama I; Matsushima K; Kaneko S; Wada T
J Rheumatol; 2009 Feb; 36(2):306-14. PubMed ID: 19208562
[TBL] [Abstract][Full Text] [Related]
2. p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice.
Iwata Y; Wada T; Furuichi K; Sakai N; Matsushima K; Yokoyama H; Kobayashi K
J Am Soc Nephrol; 2003 Jan; 14(1):57-67. PubMed ID: 12506138
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
[TBL] [Abstract][Full Text] [Related]
4. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
[TBL] [Abstract][Full Text] [Related]
5. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclophilin A on myeloblastic cell line KG-1 derived dendritic like cells (DLC) through p38 MAP kinase activation.
Bharadwaj U; Zhang R; Yang H; Li M; Doan LX; Chen C; Yao Q
J Surg Res; 2005 Jul; 127(1):29-38. PubMed ID: 15964302
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the p38 MAPK pathway ameliorates renal fibrosis in an NPHP2 mouse model.
Sugiyama N; Kohno M; Yokoyama T
Nephrol Dial Transplant; 2012 Apr; 27(4):1351-8. PubMed ID: 22076433
[TBL] [Abstract][Full Text] [Related]
8. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy.
Nishida M; Okumura Y; Sato H; Hamaoka K
Nephrol Dial Transplant; 2008 Aug; 23(8):2520-4. PubMed ID: 18515792
[TBL] [Abstract][Full Text] [Related]
9. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
Zwerina J; Hayer S; Redlich K; Bobacz K; Kollias G; Smolen JS; Schett G
Arthritis Rheum; 2006 Feb; 54(2):463-72. PubMed ID: 16447221
[TBL] [Abstract][Full Text] [Related]
10. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
Chan OT; Madaio MP; Shlomchik MJ
J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
[TBL] [Abstract][Full Text] [Related]
11. Characterization of early events involved in human dendritic cell maturation induced by sensitizers: cross talk between MAPK signalling pathways.
Trompezinski S; Migdal C; Tailhardat M; Le Varlet B; Courtellemont P; Haftek M; Serres M
Toxicol Appl Pharmacol; 2008 Aug; 230(3):397-406. PubMed ID: 18495191
[TBL] [Abstract][Full Text] [Related]
12. Lupus nephritis reoccurs following transplantation in the lupus prone mouse.
Hamar P; Wang M; Godo M; Kokeny G; Rosivall L; Ouyang N; Heemann U
Lupus; 2010 Feb; 19(2):175-81. PubMed ID: 19946036
[TBL] [Abstract][Full Text] [Related]
13. Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains.
Ma L; Chan KW; Trendell-Smith NJ; Wu A; Tian L; Lam AC; Chan AK; Lo CK; Chik S; Ko KH; To CK; Kam SK; Li XS; Yang CH; Leung SY; Ng MH; Stott DI; MacPherson GG; Huang FP
Eur J Immunol; 2005 Nov; 35(11):3364-75. PubMed ID: 16224814
[TBL] [Abstract][Full Text] [Related]
14. Effects of adding P38 mitogen-activated protein-kinase inhibitor to celsior solution in canine heart transplantation from non-heart-beating donors.
Koike N; Takeyoshi I; Ohki S; Tokumine M; Matsumoto K; Morishita Y
Transplantation; 2004 Jan; 77(2):286-92. PubMed ID: 14742995
[TBL] [Abstract][Full Text] [Related]
15. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M
Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801
[TBL] [Abstract][Full Text] [Related]
16. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
[TBL] [Abstract][Full Text] [Related]
17. Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice.
Schwarting A; Paul K; Tschirner S; Menke J; Hansen T; Brenner W; Kelley VR; Relle M; Galle PR
J Am Soc Nephrol; 2005 Nov; 16(11):3264-72. PubMed ID: 16221871
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble MD-1 levels increase with disease progression in autoimmune prone MRL(lpr/lpr) mice.
Sasaki S; Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Tsuneyama K; Hirai Y; Takatsu K
Mol Immunol; 2012 Jan; 49(4):611-20. PubMed ID: 22118968
[TBL] [Abstract][Full Text] [Related]
19. Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma.
Zhao F; Falk C; Osen W; Kato M; Schadendorf D; Umansky V
Clin Cancer Res; 2009 Jul; 15(13):4382-90. PubMed ID: 19549770
[TBL] [Abstract][Full Text] [Related]
20. The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus.
Jin N; Wang Q; Zhang X; Jiang D; Cheng H; Zhu K
Int Immunopharmacol; 2011 Sep; 11(9):1319-26. PubMed ID: 21549858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
